Bone marrow angiotensin AT2receptor deficiency aggravates atherosclerosis development by eliminating macrophage liver X receptor-mediated anti-atherogenic actions | Zendy

Taku Kato | Zendy; Hiroyuki Kawahito | Zendy; Sou Kishida | Zendy; Daisuke Irie | Zendy; Noriyuki Wakana | Zendy; Masakazu Kikai | Zendy; Hiroki Takata | Zendy; Takehiro Ogata | Zendy; Tomomi Ueyama | Zendy; Satoaki Matoba | Zendy; Hiroyuki Yamada | Zendy

Open Access

Bone marrow angiotensin AT₂receptor deficiency aggravates atherosclerosis development by eliminating macrophage liver X receptor-mediated anti-atherogenic actions

Author(s) -

Taku Kato,

Hiroyuki Kawahito,

Sou Kishida,

Daisuke Irie,

Noriyuki Wakana,

Masakazu Kikai,

Hiroki Takata,

Takehiro Ogata,

Tomomi Ueyama,

Satoaki Matoba,

Hiroyuki Yamada

Publication year - 2014

Publication title -

journal of the renin-angiotensin-aldosterone system

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 0.457

H-Index - 46

eISSN - 1752-8976

pISSN - 1470-3203

DOI - 10.1177/1470320314561138

Subject(s) - angiotensin ii , apolipoprotein e , endocrinology , medicine , proinflammatory cytokine , liver x receptor , cholesterol , angiotensin ii receptor type 1 , abca1 , bone marrow , abcg1 , inflammation , receptor , biology , biochemistry , transporter , disease , nuclear receptor , transcription factor , gene

Bone marrow (BM) Angiotensin II (Ang II) type 1 (AT1) receptor plays a crucial role in atherosclerosis development; however, the effect of BM Ang II type 2 (AT2) receptor on atherogenesis remains undefined.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research